Eli Lilly Scores In Zyprexa Patent Feud
In a blow to a group of generic drug makers, a U.S. appeals court has affirmed a lower court's decision that upheld Eli Lilly & Co.'s patent on blockbuster schizophrenia drug...To view the full article, register now.
Already a subscriber? Click here to view full article